Abstract| Volume 23, ISSUE 3, PB10, March 2022

A Deprescribing Initiative to Reduce Risk of Hypoglycemia in Long-Term Care Residents

      Polypharmacy in long-term care (LTC) facilities is an ongoing concern. To address this issue, the Drive to Deprescribe (D2D) initiative targets reduction of antihyperglycemic agents to improve quality of life and reduce risk of hypoglycemia.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect